跳至主要内容
临床试验/ISRCTN76638113
ISRCTN76638113终止1 期

Optimising Individualised prescribing with therapeutic drug Monitoring for Antipsychotics (OptIMA) 3: clinical pilot study of antipsychotic drug level monitoring for dose review - a pilot multicentre open-label single-arm clinical trial

King's College London0 个研究点目标入组 0 人开始时间: 2014年11月12日最近更新:
适应症

试验速览

阶段
1 期
状态
终止

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. People admitted to participating inpatient wards or those under the care of an outpatient clinical service
  • 2. People for whom the treating clinician has identified a need for antipsychotic dose review within routine clinical care
  • 3. Age 18-65 years
  • 4. Current diagnosis from one of the diagnostic categories of ICD-10: F20-F29
  • 5. Regularly prescribed oral olanzapine or risperidone as monotherapy for the treatment of psychotic symptoms
  • 6. Legally detained participants will be included if they have capacity to consent to the study

排除标准

  • 1. Current diagnosis of drug induced psychosis (ICD-10 F10-19)
  • 2. Use of clozapine in past 12 months

研究者

相似试验